The largest database of trusted experimental protocols

8 protocols using adenosine triphosphate (atp)

1

Mitochondrial Dynamics in Immune Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
TNF was from R&D Systems. LPS (L2630), Antimycin A, CCCP, Rotenone, Mito-TEMPO, bafilomycin A1, MG132, and CHX were from Sigma-Aldrich. ATP was from ENZO Life Sciences. TMRE, MitoTracker Deep Red, MitoTracker Green and MitoSox Red were from Life technologies. HBSS was from Cellgro. The ProcartaPlex Mouse Basic kit, mouse IL-1β Simplex and IL-18 Simplex were from eBioscience. Monoclonal antibodies used in this study are listed in Supplementary Table 1. The mCherry-Parkin plasmid was a gift from Richard Youle (Addgene plasmid # 23956)1 (link),2 (link). The following siRNA oligos were from Thermo Scientific (Dharmacon products): control siRNA (D-001210-02); ARF siRNA # 1 (5′-AGGUGAUGAUGAUGGGCAATT-3′); ARF siRNA # 2 (5′-GGUCGCAGGUUCUUGGUCATT-3′); p62 siRNA (L-047628-01); Jnk2 siRNA (5′-CCGCAGAGUUCAUGAAGAATT-3′); Jnk1 siRNA (5′-UGAUUCAGAUGGAGUUAGATT-3′); Beclin 1 (5′-CAGUUUGGCACAAUCAAUATT-3′); ATG5 siRNA (5′-CAUCAACCGGAAACUCAUTT-3′).
+ Open protocol
+ Expand
2

Neospora caninum Infection and NLRP3 Inflammasome

Check if the same lab product or an alternative is used in the 5 most similar protocols
At 3 h prior to infection, the medium was changed to complete medium (RPMI) plus 1% fetal bovine serum with or without 100 ng/ml ultrapure lipopolysaccharide (LPS; Sigma, Shanghai, China). The PMs were stimulated with N. caninum for the indicated times (1–24 h) at various multiplicities of infection (MOI = 1:1, 3:1, and 5:1). PMs treated with medium alone or LPS were used as negative controls, and cells treated with ATP (5 mM, 30 min; Sigma, Shanghai, China) were used as positive controls, as extracellular ATP is a conventional NLRP3 inflammasome agonist [14 (link)].
To monitor the role of the inflammasome in response to N. caninum infection in PMs, PMs were pre-treated with 100 μM Ac-YVAD-CHO (an inhibitor of caspase-1 and -4; Enzo Life Science, Lausen, Switzerland), 100 μM zVAD-fmk (an inhibitor of pan-caspase; Selleck, Shanghai, China) or 100 μM glyburide (an inhibitor of NLRP3 by inhibiting K+ efflux; Selleck, Shanghai, China) for 45 min before stimulation, and the PMs were then stimulated with LPS priming plus N. caninum for 12 h at an MOI of 3:1 (parasite:cell), and PMs cultured with 0.2% DMSO were used as a negative control.
+ Open protocol
+ Expand
3

THP1 Cell Inflammasome Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
THP1 cells derived from human blood with acute monocytic leukemia were obtained from American Type Culture Collection (ATCC, Manassas, VA) and were maintained in RPMI-1640 medium as per vendor instructions. PMA (Sigma-Aldrich, St. Louis, MO), nigericin (Sigma-Aldrich, St. Louis, MO), and ATP (Enzo Life Sciences, Farmingdale, NY) were purchased from its respective vendors. Anti-mouse (Cell Signaling Technology, Danvers, MA) and anti-rabbit (Cell Signaling Technology, Danvers, MA) secondary antibodies were used to detect protein expression in Western blots. Primary antibodies specific to NLRP3, ASC (Enzo Life Sciences, Farmingdale, NY), caspase-1 (Santa Cruz, Dallas, TX), IL-1β (Cell signaling Technology, Danvers, MA), and UCP2 (R&D systems, Minneapolis, MN) were purchased from its respective companies.
+ Open protocol
+ Expand
4

In Vitro SUMOylation of PVR

Check if the same lab product or an alternative is used in the 5 most similar protocols
A recombinant full-lenght human form of PVR (Abnova, H00005817) was used as substrate for in vitro SUMOylation. The reaction was carried out using 200 ng of the target protein in a 20 μL reaction volume containing E1 and E2 enzymes involved in substrate SUMOylation, SUMO 1/2/3 proteins and SUMOylation buffer for 1 hour at 37 °C in the presence of ATP, according to manufacturer’s instructions (Enzo Life Sciences). Negative control reaction omitting Mg-ATP cofactors (required for E1 activation) was performed. After in vitro SUMOylation samples were eluted with SDS-sample buffer and resolved by SDS/PAGE.
+ Open protocol
+ Expand
5

Mitochondrial Dynamics in Immune Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
TNF was from R&D Systems. LPS (L2630), Antimycin A, CCCP, Rotenone, Mito-TEMPO, bafilomycin A1, MG132, and CHX were from Sigma-Aldrich. ATP was from ENZO Life Sciences. TMRE, MitoTracker Deep Red, MitoTracker Green and MitoSox Red were from Life technologies. HBSS was from Cellgro. The ProcartaPlex Mouse Basic kit, mouse IL-1β Simplex and IL-18 Simplex were from eBioscience. Monoclonal antibodies used in this study are listed in Supplementary Table 1. The mCherry-Parkin plasmid was a gift from Richard Youle (Addgene plasmid # 23956)1 (link),2 (link). The following siRNA oligos were from Thermo Scientific (Dharmacon products): control siRNA (D-001210-02); ARF siRNA # 1 (5′-AGGUGAUGAUGAUGGGCAATT-3′); ARF siRNA # 2 (5′-GGUCGCAGGUUCUUGGUCATT-3′); p62 siRNA (L-047628-01); Jnk2 siRNA (5′-CCGCAGAGUUCAUGAAGAATT-3′); Jnk1 siRNA (5′-UGAUUCAGAUGGAGUUAGATT-3′); Beclin 1 (5′-CAGUUUGGCACAAUCAAUATT-3′); ATG5 siRNA (5′-CAUCAACCGGAAACUCAUTT-3′).
+ Open protocol
+ Expand
6

In vitro ubiquitination assay of IRGM1

Check if the same lab product or an alternative is used in the 5 most similar protocols
His-IRGM1 was expressed in E.coli and purified with Ni2+-NTA (GE Healthcare). His-IRGM1 was incubated with 200 ng E1 (UBE1), 500 ng E2 (UbcH5c), 10 μg His-Ub and 2 mM ATP (Enzo life sciences). The reaction was performed in the absence and presence of Flag-CUL4B co-IP products and incubated at 37 °C for 1 h. Samples were quenched in 6 M guanidinium-HCl (pH=8) containing 5 mM NEM. His-ubiquitinated proteins were pulled down with Ni2+-NTA (GE Healthcare), washed and eluted in sample buffers as described previously [27 (link)]. The mixture was then boiled in loading dye at 95 °C for 10 mins to disrupt the protein-protein interactions, followed by Western blot.
+ Open protocol
+ Expand
7

miR-221-5p Regulation of JNK2 Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
LPS (L2630), β-actin antibody (AC-15), and actinomycin D were from Sigma-Aldrich. ATP was from ENZO Life Sciences. JNK2 antibody was from Cell Signaling Technology (Cat # 4672). AGO2 antibody was from abcam (ab186733). Mouse miRIDIAN miR-221-5p mimic, miRIDIAN miRNA mimic negative control, miRIDIAN mouse miR-221-5p hairpin inhibitor, and miRIDIAN miNA hairpin inhibitor negative control were from Horizon Discovery. Ad/JNK2 was generated by ViraQuest, Inc. by cloning pCDNA3 Flag Jnk2a2 (Addgene, Item ID 13755) into the pVQAd CMV K-NpA vector. Ad/null was from ViraQuest, Inc. miR-221-5p inhibitor and inhibitor control, and miR-221-5p mimic and mimic control were from Horizon Discovery.
+ Open protocol
+ Expand
8

Inflammasome Activation and IL-1β Secretion

Check if the same lab product or an alternative is used in the 5 most similar protocols
PMA (Sigma-Aldrich, St. Louis, MO, USA), nigericin (Sigma-Aldrich), glyburide (Sigma-Aldrich), ATP (Enzo lifesciences, Farmingdale, NY, USA), KCl (Sigma-Aldrich), TAPI-2 (EMD chemicals, Gibbstown, NJ, USA), AG-825 (EMD chemicals), recombinant human IL-1β (rhIL-1β, R&D systems, Minneapolis, MN, USA) and IL-1βRA (rhIL-1β, R&D systems) were purchased from its respective vendors. The following secondary antibodies were used to detect protein expression: anti-rabbit HER2 (Santacruz biotechnology, Santa Cruz, CA, USA), anti-rabbit pHER2 (Santacruz biotechnology), anti-mouse NRG-1(Neo markers, Fremont, CA, USA) primary, anti-mouse (Cell Signaling Technology, Danvers, MA, USA) and anti-rabbit (Cell Signaling Technology).
Treatment with inflammasome stimulators or inhibitors THP-1 cells were differentiated by adding 0.5 µg/ml of PMA to the medium for 3 hours, then the medium was replaced with RPMI plus 0.1% serum overnight. After 24 hours, cells were briefly washed with PBS. Then, 0.5 µg/ml of nigericin or 0.25 mM ATP, in the presence or absence of 1.25 µg/ml glyburide or 130 mM KCl, was added to the medium for 1 hour. The activation of the inflammasome was confirmed by measuring the IL-1β secretion, and the supernatant was added to 80% confluent epithelial or endothelial cells for up to 5% of the mentioned time.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!